Infographics
TMT
Why India's B2B unicorns are more capital-efficient than B2C startups
Indian or Indian-origin technology unicorns that focus on the business-to-business segment are more capital-efficient than their...
Finance
GIC rebuilds stake in PE-backed Indian life insurer
Singapore’s GIC Pte. Ltd, one of the most active sovereign wealth funds in India, has again started building its exposure...
Infrastructure
Is GIC-backed Gayatri Projects really on the fast road to revival?
Numbers can be deceptive. And highway developer Gayatri Projects Ltd only proves this. At first glance, the company appears...
Finance
India's love for cash hinders move to digital economy despite demonetisation push
India's dependency on cash may slow the country's transition to digital payments despite large numbers of internet and...
Finance
Fund Scan: How Aditya Birla Private Equity lost its momentum
A little more than four years ago, Aditya Birla Private Equity invested in a Mumbai-based fashion garments maker. The September...
Markets
Passive equity funds set to beat active funds for second year
India's passive index-tracking equity funds are set to beat their active stock-picking counterparts in returns for a second...
Infrastructure
In Charts: How India's $5 tn GDP dream faces mounting infra delays, cost overruns
After reviewing nine mega projects worth Rs 61,000 crore last week, prime minister Narendra Modi emphasised two things: “Speedy...
Finance
How ChrysCapital's partial exit from drugmaker panned out
ChrysCapital has sold another chunk of its stake in a Mumbai-based drugmaker, as the homegrown private equity firm positions itself...
Infrastructure
Can road builder Sadbhav beat revenue doldrums amid shrinking order book, debt woes?
At first glance, highway developer Sadbhav Engineering Ltd seems to have a debt problem. The debt nearly doubled in five ......
Healthcare
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry...
